carnitine has been researched along with ranolazine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Allely, MC; Brown, CM; Kenny, BA; Kilpatrick, AT; Martin, A; Spedding, M | 1 |
| Ribeiro, C | 1 |
| Chierchia, SL; Fragasso, G | 1 |
| Iliceto, S; Marangelli, V; Rizzon, P | 1 |
| Abiko, Y; Hara, A; Hashizume, H; Maruyama, K; Ushikubi, F | 1 |
| Andreadou, I; Cicchitelli, G; Ferrari, R; Guardigli, G; Merli, E | 1 |
| Hill, JA; Schofield, RS | 1 |
| McCarty, MF | 1 |
| Sweeney, M | 1 |
| Pauly, DF; Pepine, CJ | 1 |
| Arora, R; Parang, P; Singh, B | 1 |
| César, LA; Gowdak, LH; Mansur, AP | 1 |
| Lango, R | 1 |
| Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M | 1 |
| Aldaz, P; Arozarena, I; Bocanegra, A; Feliu, I; Fernandez-Irigoyen, J; Gomez-Cabrero, D; Larrayoz, IM; Lasheras-Otero, I; Lecanda, F; Maillo, A; Moreno, H; Olias-Arjona, A; Redondo-Muñoz, M; Santamaria, E; Vicent, S; Wellbrock, C | 1 |
9 review(s) available for carnitine and ranolazine
| Article | Year |
|---|---|
Metabolic management of ischaemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Energy Metabolism; Humans; Myocardium; Nitroglycerin; Piperazines; Ranolazine; Trimetazidine | 1993 |
Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease?
Topics: Acetanilides; Carnitine; Clinical Trials as Topic; Coenzymes; Coronary Disease; Enzyme Inhibitors; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Superoxide Dismutase; Trimetazidine; Ubiquinone; Vasodilator Agents | 1995 |
Metabolic modulation and optimization of energy consumption in heart failure.
Topics: Acetanilides; Cardiac Pacing, Artificial; Cardiotonic Agents; Carnitine; Energy Metabolism; Heart Failure; Humans; Piperazines; Ranolazine; Trimetazidine | 2003 |
Role of metabolically active drugs in the management of ischemic heart disease.
Topics: Acetanilides; Animals; Cardiovascular Agents; Carnitine; Clinical Trials as Topic; Dichloroacetic Acid; Energy Metabolism; Fatty Acids; Glucose; Humans; Insulin; Myocardial Ischemia; Myocardium; Piperazines; Potassium; Ranolazine; Trimetazidine | 2001 |
Ischemic heart disease: metabolic approaches to management.
Topics: Acetanilides; Cardiovascular Agents; Carnitine; Dichloroacetic Acid; Energy Metabolism; Humans; Myocardial Ischemia; Oxidation-Reduction; Piperazines; Ranolazine; Ribose; Trimetazidine | 2004 |
Metabolic modulators for chronic cardiac ischemia.
Topics: Acetanilides; Animals; Carnitine; Chronic Disease; Drug Evaluation, Preclinical; Enzyme Inhibitors; Heart; Humans; Lipid Metabolism; Myocardial Ischemia; Myocardium; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2005 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease; Dichloroacetic Acid; Humans; Piperazines; Quality of Life; Ranolazine; Ribose; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2009 |
[Regulation of myocardial metabolism: possibilities and application in cardiac surgery].
Topics: Acetanilides; Animals; Cardiac Surgical Procedures; Cardiotonic Agents; Carnitine; Drug Therapy, Combination; Glucose; Glutamine; Humans; Insulin; Intraoperative Care; Myocardial Stunning; Myocardium; Myocytes, Cardiac; Piperazines; Potassium; Ranolazine; Trimetazidine; Vasodilator Agents | 2003 |
Metabolic support for the heart: complementary therapy for heart failure?
Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine | 2016 |
7 other study(ies) available for carnitine and ranolazine
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine.
Topics: Acetanilides; Animals; Carnitine; Carnitine O-Palmitoyltransferase; Dihydroalprenolol; Dihydropyridines; In Vitro Techniques; Male; Myocardial Ischemia; Palmitoylcarnitine; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha | 1993 |
[Therapeutic application of myocardial cytoprotection].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 1994 |
Ranolazine attenuates palmitoyl-L-carnitine-induced mechanical and metabolic derangement in the isolated, perfused rat heart.
Topics: Acetanilides; Adenosine Triphosphate; Animals; Carnitine; Enzyme Inhibitors; Heart; In Vitro Techniques; Male; Piperazines; Pyruvate Dehydrogenase Complex; Ranolazine; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2000 |
A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets.
Topics: Acetanilides; Angina Pectoris; Carnitine; Chemotherapy, Adjuvant; Diet, Fat-Restricted; Diet, Vegetarian; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids; Heart; Humans; Piperazines; Ranolazine; Sympathetic Nervous System | 2004 |
Effects of very low-fat diets on anginal symptoms.
Topics: Acetanilides; Angina Pectoris; Carnitine; Chemotherapy, Adjuvant; Diabetes Complications; Diabetes Mellitus; Diet, Fat-Restricted; Diet, Vegetarian; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids; Heart; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2004 |
The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma.
Topics: Animals; Carnitine; Carnitine Acyltransferases; Carnitine O-Acetyltransferase; Fatty Acids; Melanoma; Mice; Neoplastic Cells, Circulating; Oxidation-Reduction; Ranolazine | 2023 |